We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
(+11%)
Cap. Flow
+$23.3M
Cap. Flow
% of AUM
11.78%
Top 10 Holdings %
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delek US
DK
|
+$871K |
| 2 |
Broadcom
AVGO
|
+$691K |
| 3 |
Agilent Technologies
A
|
+$650K |
| 4 |
Telos
TLS
|
+$640K |
| 5 |
Pagaya Technologies
PGY
|
+$627K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Array Technologies
ARRY
|
+$730K |
| 2 |
Vertiv
VRT
|
+$639K |
| 3 |
Zevra Therapeutics
ZVRA
|
+$635K |
| 4 |
BOW
Bowhead Specialty Holdings
BOW
|
+$608K |
| 5 |
Rigel Pharmaceuticals
RIGL
|
+$581K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Industrials | 15.13% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 11.79% |
| 5 | Healthcare | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Match Group
MTCH
$9.16B
| $266K | 0.13% |
+8,235
| New | +$271K |
|
352
South Plains Financial
SPFI
$855M
| $266K | 0.13% |
6,848
-2,500
| -27% | -$95.7K |
|
353
Ally Financial
ALLY
$13.4B
| $265K | 0.13% |
5,860
-6,013
| -51% | -$248K |
|
354
Custom Truck One Source
CTOS
$2.35B
| $265K | 0.13% |
+46,029
| New | +$281K |
|
|
FFIC
355
DELISTED
Flushing Financial
FFIC
| $264K | 0.13% |
+17,433
| New | +$264K |
|
356
Funko
FNKO
$355M
| $264K | 0.13% |
77,761
+41,004
| +112% | +$129K |
|
357
Evertec
EVTC
$1.94B
| $264K | 0.13% |
+9,083
| New | +$270K |
|
358
Encompass Health
EHC
$11.5B
| $264K | 0.13% |
+2,483
| New | +$288K |
|
359
ThredUp
TDUP
$760M
| $262K | 0.13% |
41,066
+15,590
| +61% | +$126K |
|
360
First Bancorp
FBP
$4.47B
| $262K | 0.13% |
+12,650
| New | +$261K |
|
|
UCB
361
United Community Banks
UCB
$4.27B
| $262K | 0.13% |
+8,399
| New | +$259K |
|
362
Federated Hermes
FHI
$4.59B
| $262K | 0.13% |
+5,035
| New | +$256K |
|
363
TaskUs
TASK
$568M
| $262K | 0.13% |
+22,193
| New | +$284K |
|
364
CF Industries
CF
$18.9B
| $261K | 0.13% |
3,380
-1,281
| -27% | -$105K |
|
365
Diamondrock Hospitality Co
DRH
$2.67B
| $261K | 0.13% |
29,168
+13,899
| +91% | +$118K |
|
366
Simply Good Foods
SMPL
$941M
| $261K | 0.13% |
13,006
-1,518
| -10% | -$31.6K |
|
367
PJT Partners
PJT
$4.47B
| $261K | 0.13% |
+1,561
| New | +$267K |
|
368
Cognyte Software
CGNT
$657M
| $260K | 0.13% |
27,706
+2,995
| +12% | +$25.9K |
|
|
ECO
369
Okeanis Eco Tankers
ECO
$2.28B
| $260K | 0.13% |
+7,696
| New | +$261K |
|
370
Titan Machinery
TITN
$458M
| $259K | 0.13% |
+17,248
| New | +$278K |
|
371
PACS Group
PACS
$7.43B
| $259K | 0.13% |
6,746
-7,814
| -54% | -$171K |
|
372
Banco Macro
BMA
$5.81B
| $259K | 0.13% |
+2,870
| New | +$217K |
|
373
Cimpress
CMPR
$2.43B
| $259K | 0.13% |
3,885
-1,573
| -29% | -$107K |
|
374
Trupanion
TRUP
$1.11B
| $258K | 0.13% |
+6,910
| New | +$271K |
|
375
FerroAtlántica
GSM
$628M
| $257K | 0.13% |
+55,392
| New | +$256K |
|
Similar funds
BS
RG
MP
CCM
DFA
CCP
FRT
VH
PharVision Advisers's Q4 2025 Portfolio in Review
As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.
- PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
- PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
- PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
- PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
- PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
- PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
- PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.
Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.